Compass Therapeutics (NASDAQ:CMPX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Compass Therapeutics (CMPX) operate in?

Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile.

Open	$3.10
Close	$2.92
Volume / Avg.	1.13M / 1.35M
Day Range	$2.85 - $3.20
52 Wk Range	0.77 - 4.08
Market Cap	$412.77M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	2.82%
Days to Cover	1.54

Recent News

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Top 3 High-Momentum Companies Analysts Are Still Bullish On

The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline.

MarketBeat

Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.10
Close	$2.92
Volume / Avg.	1.13M / 1.35M
Day Range	$2.85 - $3.20
52 Wk Range	0.77 - 4.08
Market Cap	$412.77M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	2.82%
Days to Cover	1.54

About Compass Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary ant...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Compass Therapeutics (CMPX) stock?

You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.

View our list of the best stock brokerages

Who are Compass Therapeutics (CMPX) competitors?

Other companies in Compass Therapeutics’s space includes: Upstream Bio (NASDAQ:UPB), Sage Therapeutics (NASDAQ:SAGE), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA) and PureTech Health (NASDAQ:PRTC).

What is the forecast, or price target, for Compass Therapeutics (CMPX) stock?

Compass Therapeutics has a consensus price target of $11.33.

What is the current price for Compass Therapeutics (CMPX)?

The stock price for Compass Therapeutics (NASDAQ: CMPX) is $3 last updated February 21, 2025 at 5:59 PM EST.

Does Compass Therapeutics (CMPX) pay a dividend?

There are no upcoming dividends for Compass Therapeutics.

When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?

Compass Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Compass Therapeutics (CMPX) going to split?

There is no upcoming split for Compass Therapeutics.

What sector and industry does Compass Therapeutics (CMPX) operate in?

Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Compass Therapeutics

Compass Therapeutics (CMPX) Forecast